编辑 徐雨婷 校对 卢茜 新京报贝壳财经讯（记者罗亦丹）1月17日，萝卜快跑与阿联酋自动驾驶出行公司AutoGo合作取得关键 进展——双方宣布在阿布扎比正式启动面向公众的全无人驾驶商业化运营。即日起，当地居民和游客可 通过AutoGo App呼叫萝卜快跑全无人驾驶车辆，服务率先从亚斯岛（Yas Island）开始，并计划逐步拓 展至阿布扎比更多区域。 这是萝卜快跑首次在海外推出面向公众的全无人驾驶出行服务，标志着中国无人驾驶技术在商业化与国 际化进程中迈出关键一步。亚斯岛作为中东知名综合性度假区，汇集了法拉利世界、华纳兄弟主题公园 等多个世界级景点。 目前，萝卜快跑无人驾驶出行服务已覆盖全球包括迪拜、阿布扎比在内的22座城市，累计订单量突破 1700万单。公司全球化布局正持续提速，预计将于2026年初在英国伦敦开启无人驾驶测试及出行服务， 进一步拓展其全球网络。 ...

新京报讯（记者刘欢）1月17日，新京报记者获悉，由北京市通州区潞城镇人民政府主办的"城市副中心 食品健康产业高质量发展研讨会暨'扎根潞城'合作意向签约仪式"近日举行。活动发布《潞城镇"食品健 康产业领军企业培育计划"》，旨在吸引和培育潞城食品健康产业领军企业，加快建设北京城市副中心 （潞城）食品健康小镇。 据悉，本次活动旨在汇聚政产学研多方智慧，为把潞城打造成为北京城市副中心食品健康产业高地、培 育百亿级都市食品产业集群注入强劲动能。会议期间，《潞城镇"食品健康产业领军企业培育计划"》正 式发布。该计划提出，将通过实施空间保障降本工程、企业联盟生态工程、智库智力赋能工程、品牌市 场增效工程等四大工程，精准破解企业发展瓶颈，加速培育一批创新能力强、品牌影响力广、带动作用 突出的食品健康产业领军企业，助力北京城市副中心（潞城）食品健康小镇高质量发展。 编辑 唐峥 校对 张彦君 值得关注的是，潞城打造食品健康产业集群并非凭空构想，而是建立在扎实的产业基础之上。自2002年 设立食品工业园区以来，这里已集聚了蒙牛、二商肉食、白玉、苏稻等50家食品企业，形成 了"1+6+1"现代化农业产业格局。目前，区域食品产业年产值 ...

【#逾300家A股公司发布2025年业绩预告#】数据显示，截至1月16日收盘，有超过300家A股公司发布了 2025年业绩预告。其中，有6家公司预计2025年归属于上市公司股东的净利润超过百亿元。发布2025年 业绩预告的公司中，多家有色金属相关公司预计去年业绩良好。例如，紫金矿业预告的净利润（下限） 目前排在首位。公告显示，紫金矿业预计2025年度实现归属于上市公司股东的净利润约510亿元至520亿 元，同比增长约59%至62%。从已公布的上市公司业绩预报来看，多家光伏行业上市公司2025年业绩承 压。 (证券日报) ...

【#京东将发力自提外卖##京东部分自提食品低至0.01元# 】记者从京东获悉，京东将发力自提外卖业 务，于1月18日开启促销活动，部分自提食品低至0.01元。消费者打开京东App点击"秒送"频道，搜 索"外卖请客"进入会场，或找到"自提更省"标识定位自提美食，到店自提减1元。 (新京报) ...

Group 1 - The core focus of the article is that JD.com is expanding its self-pickup food delivery service, launching a promotional campaign on January 18, with some self-pickup food items priced as low as 0.01 yuan [1] - Consumers can access the promotion by opening the JD.com app, navigating to the "秒送" channel, and searching for "外卖请客" or locating the "自提更省" label for self-pickup food options, which offers a discount of 1 yuan for in-store pickup [1]

新京报贝壳财经讯 1月16日，胜宏科技公告，预计2025年度归属于上市公司股东的净利润为41.6亿元～ 45.6亿元，比上年同期增长260.35%～295.00%；扣除非经常性损益后的净利润为41.5亿元～45.5亿元， 比上年同期增长263.59%～298.64%。业绩增长主要得益于公司在AI算力、数据中心、高性能计算等关 键领域的高端产品大规模量产，推动业绩高速增长。 ...

新京报贝壳财经讯 澜起科技1月16日公告，预计2025年度实现归属于母公司所有者的净利润21.5亿元— 23.5亿元，较上年同期增长52.29%—66.46%。受益于AI产业趋势，行业需求旺盛，公司互连类芯片出货 量显著增加，推动公司2025年度经营业绩较上年同期实现大幅增长。 ...

Core Viewpoint - Lishang Guochao expects a significant increase in net profit for the year 2025, projecting a rise of 92.96% to 134.3% compared to the previous year [1] Financial Projections - The company anticipates a net profit attributable to shareholders of 140 million to 170 million yuan for 2025, an increase of 67.4475 million to 97.4475 million yuan year-on-year [1] - The projected net profit, excluding non-recurring gains and losses, is expected to be between 138 million and 168 million yuan, reflecting an increase of 23.5638 million to 53.5638 million yuan compared to the previous year [1] - The year-on-year growth for the net profit excluding non-recurring items is estimated to be between 20.59% and 46.81% [1]

Core Viewpoint - The brain-computer interface (BCI) sector in the A-share market has shown significant activity at the beginning of 2026, with a cumulative increase of 18.04% in the BCI theme index as of January 16, 2026, indicating a strong interest and potential for commercialization in this emerging industry [2][4]. Industry Overview - The BCI industry is projected to reach a market size of trillions, transitioning from laboratory research to commercial applications, driven by advancements in technology and supportive government policies [3]. - The Ministry of Industry and Information Technology and other departments have emphasized the importance of BCI in their strategic plans, including its inclusion in the "14th Five-Year Plan" for future industrial development [3]. Market Performance - As of January 16, 2026, the total market capitalization of 26 listed companies in the BCI sector has increased by approximately 108.7 billion yuan over ten trading days [8]. - Notable companies like Innovation Medical and Meihua Medical have experienced significant stock price fluctuations, reflecting the volatile nature of the market and investor sentiment towards BCI technologies [5][7]. Company Developments - Innovation Medical's subsidiary, Boling Brain Machine Technology, has launched products aimed at rehabilitation for stroke patients, although it reported operating losses of 6.6 million yuan and 8.66 million yuan in 2023 and 2024, respectively [6]. - Meihua Medical, a leader in cochlear implants, is actively collaborating with BCI clients to facilitate the transition from laboratory research to commercial production, highlighting the interconnectedness of BCI and existing medical technologies [7]. Strategic Collaborations - Companies like Yahui Long and Shenzhen Brain Machine Star Chain Technology have entered strategic partnerships to develop BCI-related products, aiming to enhance diagnostic and treatment capabilities in central nervous system diseases [9]. - Aipeng Medical is also expanding its business into BCI applications, focusing on pain management and sleep disorders, indicating a broader trend of diversification within the medical device sector [9]. Technical Insights - The core technological barriers in the BCI industry are concentrated in the upstream supply chain, including hardware components and surgical techniques, with significant potential for growth in domestic market penetration and localization [10].

Group 1 - The core point of the article is that Moutai has opened the purchase of its 1499 yuan/bottle Flying Moutai (53 degrees, 500ml) to tax-compliant enterprises through its provincial direct stores [1] - Compared to last year, the policy has been significantly optimized, allowing compliant enterprises to purchase the Flying Moutai at a standard price without needing to buy other non-standard Moutai products [2] - Moutai's sales company confirmed that the direct stores are currently signing sales contracts for 2026 with existing corporate group purchase clients, and the products sold will be selected based on the consumption needs of these clients [2]